Category:

27 April 2022

RESOLUTIONS OF THE SHAREHOLDERS’ MEETING OF 27/04/2022

11 April 2022

BUY-BACK REPORT MARCH 2022

31 March 2022

NOTICE OF PUBLICATIONOF THE 2021 ANNUAL FINANCIAL REPORT

18 March 2022

PHARMANUTRA S.P.A.: FILING OF DOCUMENTS FOR THE SHAREHOLDERS’ MEETING

18 March 2022

PHARMANUTRA S.P.A.: THE BOARD APPROVES THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS AT 31 DECEMBER 2021

08 March 2022

BUY-BACK REPORT FEBRUARY 2022

23 February 2022

MODIFICATION OF THE 2022 CORPORATE EVENTS CALENDAR

14 February 2022

THE EUROPEAN UNION AUTHORISES MARKETING OF CFAs AS A NOVEL FOOD

07 February 2022

Buy-back report January 2022

31 January 2022

PHARMANUTRA S.P.A. CONFIRMS STRONG SALES INCREASE

24 January 2022

PHARMANUTRA S.P.A.: INITIATION OF SHARE BUY-BACK PROGRAM

17 January 2022

PHARMANUTRA S.P.A.: NEW LICENCE GRANTED IN THE U.S.A.

14 January 2022

PUBLICATION OF THE 2022 CORPORATE EVENTS CALENDAR

13 January 2022

PHARMANUTRA S.P.A. STRENGTHENS PRESENCE ON TAIWANESE MARKET

02 December 2021

PHARMANUTRA S.P.A. JOINS THE “MSCI WORLD SMALL CAP” AND “FTSE ITALIA MID CAP” INDICES

25 November 2021

PHARMANUTRA GROUP: THREE NEW PATENTS RELEASED

16 November 2021

NEW INTERNATIONAL AGREEMENT FOR THE DISTRIBUTION OF SIDERAL® IN ARGENTINA

12 November 2021

INTERIM FINANCIAL REPORT AS OF 30 SEPTEMBER 2021

08 November 2021

BOARD OF DIRECTORS APPROVES INTERIM MANAGEMENT REPORT AS AT 30 SEPTEMBER 2021

25 October 2021

PHARMANUTRA S.P.A.: ALESCO SUBSIDIARY OBTAINS PATENT FOR THE NEW SUCROSOMIAL® BERBERINE

21 October 2021

PHARMANUTRA S.P.A. OBTAINS THE GRANT OF CETILAR® PROCESS PATENT IN INDIA

< 1 … 3 4 5 … 11 >